A recent study indicates that people who stop using blockbuster GLP-1 drugs like semaglutide or tirzepatide tend to recover lost weight much more quickly than those who halt conventional diet and exercise programs.
Research printed in a leading health publication demonstrates that while obese people often shed substantial amounts of their total mass while on the medication, the mass comes back at an average rate of nearly a kilo each month upon discontinuation.
"Individuals using such drugs need to be informed of the danger of quick weight regain when the treatment concludes," cautioned lead investigator Dr. Susan Jebb.
Such speed of regain suggests a return to starting mass in about 18 months.
Comparing Therapies
The analysis, which looked at dozens of studies involving over 9,000 of participants, contrasted the effects of the injectable medications with other pills.
Scientists point out that people who lose weight through diet and exercise usually experience a more gradual creep back—around 100 grams monthly—after stopping.
Understanding the Rapid Regain
Doctors believe the way of the jabs accounts for the accelerated rebound.
GLP-1 drugs copy a body's own chemical called GLP-1, which controls hunger.
"Sustained high doses of GLP-1 concentrations several times higher than the body's typical production may cause the body to generate a reduced amount of its endogenous GLP-1, and may also reduce sensitivity to its effects," noted Dr. Adam Collins, a nutrition expert.
"Discontinuation of this GLP-1 'fix' means hunger is unsuppressed, making excessive eating a significant risk."
A Chronic Issue?
Health authorities suggest the jabs for individuals with obesity-related health risks, alongside prescribed lifestyle changes.
Many experts contend that, given the significant potential of weight regain, the therapy should be considered life-long.
This view is supported by pharmaceutical companies, who say that the results "underscore the long-term character of excess weight," similar to managing conditions like high blood pressure.
User Testimonies
Users who have stopped the medication explain a intense resurgence of cravings.
"It was like something activating and you're instantly ravenous," said one woman.
The struggle is worsened if individuals have not adopted permanent lifestyle or habit changes during therapy.
Widespread Interest
Figures indicate that a significant number of adults in the UK have tried these injections in the past year, with demand being substantial.
- Adoption is more common among females than men.
- The 40s and 50s demographic shows the greatest level of interest.
- Many obtain the medications through private prescriptions rather than public health services.
In conclusion, experts caution that while these medications are powerful tools for weight loss, they are not a permanent solution and lasting health benefits relies on integrated lifestyle changes.
